Quality Management Review: Benchmarking Quantitatively!

» This is a free bonus issue for all subscribers. Only paid subscribers access our regular monthly newsletters with exclusive analysis. Upgrade to a paid subscription here.

---

In an episode of our podcast, The Life Science Rundown, The FDA Group's Nick Capman spoke with Tobias Kuners of Koenders, Managing Consultant at Tob Management, to discuss his integrated approach to implementing and interpreting qualitative and quantitative metrics in the GMP and non-GMP sides of a life science business.

Apple | Spotify | YouTube | Web + Others

Read Tobias’s full column in Pharmaceutical Online »

Tobias has worked with Biogen, Ipsen, Thermo Fisher, Kite Pharma, and Danone, among other companies, gaining hands-on experience in engineering services, equipment qualification, maintenance, supply chain, warehousing, and distribution. He has led the design, engineering, and construction of multiple facilities to meet cGMP requirements. He performs audits, identifies gaps, and develops remediation plans, working within organizations to assist with deviation investigations and CAPA implementation and to develop scientific, risk-based solutions.

---

Not a paid subscriber yet?

Here’s what you’re missing:

• 🔒 FDA Revives Its Proposed Quality Metrics for Pharma and Clarifies Device Cybersecurity Recommendations + Warning Letter Breakdown

• 🔒 Revisions to Q9(R1) Quality Risk Management, Getting "Recall Ready" + Warning Letter Breakdown

• 🔒 Reviewing RMPs Against FDA's Drug Shortage Guidance, Inside FDA's Device VIP + Warning Letter Breakdown

• 🔒 Reporting CMC Post-Approval Changes, Proactively Addressing the Root Causes of Medical Device Recalls + Warning Letter Breakdown

• 🔒 Alternative cGMP Compliance Methods for Combo Products, Device Production and Quality System Software Assurance + Warning Letter Breakdown

• 🔒 Revised Compliance Guides for PAIs and GMP Drug Inspections, New Guidances On Device Post-Approval Studies, Postmarket Surveillance + Warning Letter Breakdown

• 🔒 Implementing ICH Q14’s Enhanced Approach to Analytical Method Development, FDA's Proposed Framework for Human Factor Info in Device Submissions + Warning Letter Breakdown

• 🔒 FDA Finalizes Guidance on REMS Format and Content, Preparing for Expanded Device Inspection Authority + Warning Letter Breakdown

• 🔒 “The Compliance Issue” Addressing the Top-Cited CFRs to Pharma and Device Firms + Warning Letter Breakdown

Upgrade here to unlock all of these issues and new ones »

---

The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates.

Need expert help planning and executing compliance projects or connecting with a quality and compliance professional? Get in touch with us. If we haven’t worked together yet, watch our explainer video below or head to our company introduction page to see if we could help you execute your projects now or in the future.

Our service areas:

Quality Assurance | Regulatory Affairs | Clinical Operations | Commissioning, Qualification, and Validation | Manufacturing and Engineering | Expert Witness

Our engagement models:

Consulting Projects | Staff Augmentation | FTE Recruitment | Functional Service Program

Our podcast:

Apple | Spotify | YouTube | Web + Others